Parkinson's Disease Enhanced Primary Care Pathway [January …€¦ · · 2017-04-28snack or...
Transcript of Parkinson's Disease Enhanced Primary Care Pathway [January …€¦ · · 2017-04-28snack or...
January2017-1
CALGARY AND AREA
Specialist LINKLinking Physicians
PatientName: DateofReferral:
DateofBirth: ReferringMD:
CalgaryRHRN: Fax:
PHN/ULI: Today’sDate:
CONFIRMATION: ReferralReceived
TRIAGECATEGORY: EnhancedPrimaryCarePathway:Parkinson’sDisease
REFERRALSTATUS: ACCEPTEDconsideractionsinthemedicalhomeasoutlinedbelowDearColleague,Theclinicalanddiagnosticinformationyouhaveprovidedfortheabove-namedpatientisconsistentwithParkinson’sDisease.TheDivisionofNeurologyhaschangedthetriagemanagementofcertainmovementdisorderstoshortenwaittimesandyourpatientwillbeseenmorerapidlybyaGENERALNEUROLOGIST.ConsultationswiththeSUBSPECIALITYMOVEMENTDISORDERNEUROLOGISTwilloccurifandwhenthecasebecomesmorecomplex.Ifyoufeelthereissufficientfunctionalimpairmentindailyactivities,PLEASEstartlevodopa(Sinemet)priortothispatientbeingassessed.Themedicationiswelltoleratedandapositiveresponsetomedicationwillnothinderconfirmationofthediagnosis–infact,improvementofsymptomsandsignswiththismedicationmaysupportyourclinicaldiagnosis.Resourcesforpatientsaswellasguidelinesforinitiatinglevodopaareattached.PLEASEalsoconsiderareferraltocommunityphysiotherapyorCommunityAccessibleRehab(CAR)ortheFALLSclinicnotingParkinson’sDiseaseasthediagnosisifthereissufficientfunctionalimpairment.ThisclinicalpathwayandcareadvicehasbeendevelopedbytheCalgaryZonePrimaryCareNetworksinpartnershipwiththeSectionofNeurologyandAlbertaHealthServices.Theselocalguidelinesarebasedonbestavailableevidence,currentlocalresourcesandarepracticalintheprimarycaresettingThisreferralisACCEPTEDandanappointmenttimeispendingwithaGeneralNeurologist.Thepatientwillbecontacteddirectlywithappointmentinformationonceavailable.ForgeneraladviceonpatientcarefromaNeurologistinthiscaseorothers,callSpecialistLINK,aneurologyphoneconsultationservice,available08:00-17:00weekdaysat403.910.2551ortoll-freeat1.844.962.5465.Thankyou,CentralAccessandTriageSectionofNeurologyDepartmentofClinicalNeurosciences
January2017-2
EnhancedPrimaryCarePathway:Parkinson’sDisease
1.FocusedsummaryofPDrelevanttoprimarycare
Parkinson’sDisease(PD)andEssentialtremor(ET)aretwoofthemostcommonmovementdisordersencounteredbyfamilydoctors;bothpresentwithtremorbutthetwodisordersaretreateddifferently.ThediagnosisofPDisclinical.Wherethereisfunctionalimpairment,treatmentcanproducesignificantbenefitandmaybeinitiatedwithoutaneurologyreferral.Parkinson’sDiseaseischaracterizedbytremorATREST(notwhileholdingobjects),cogwheelrigidity,bradykinesia(slowness)andbalancedifficulty(posturalinstability).Patientscomplainofunilateralonsetoftremorwhiletheirhandisatrest,smallhandwritingincomparisontothepast(micrographia),decreasedfacialexpression,softvoice(hypophonia),andstiffnessresultinginslowmovement(bradykinesia).Overyears,thesesignsandsymptomsspreadtobecomebilateral.ThemnemonicTRAPisoftenusedasareminderofthecardinalfeaturesofidiopathicPD,consistingof:restingTremor,cogwheelRigidity,Akinesiaorbradykinesia,andPosturalinstability.Other“non-motor”symptoms,presentatearlystagesofthediseaseincludedecreasedolfaction,depressionandanxiety,balancedifficulty,constipation,bladderdysfunctionandseeming“actingoutofdreams”whileinbedatnight(REMsleepbehaviordisorder).Druginducedparkinsonismshouldbeexcluded.Commonculpritdrugsincludemetoclopramide(usedtotreatnausea)aswellasavarietyofantipsychoticmedications(haloperidol,olanzapine,aripiprazole,pimozideandrisperidone).Assistancefrompsychiatrywillbeneededinchangingantipsychoticmedicationstomedicationssuchasquetiapineorclozapine.IfthereissufficientfunctionalimpairmentofdailyactivitiesinidiopathicParkinson’sDisease,medicaltreatmentisindicated.OfallthedrugsavailabletotreatPD,levodopahasthegreatestefficacywiththefewestsideeffectssoisthedrugofchoice.LevodopacomesinmultipleformulationsbutSinemetregular100/25(levodopa/carbidopa),yellowincolour,(notSinemetCR)shouldbeused.PatientswithPDshowdramaticbenefittoadequatedosesoflevodopa,whichimprovestremorandbradykinesia,gaitandfacialexpression.Section4describesanexampletitrationscheduleforthismedication.ThereareanumberofsimilarneurodegenerativesyndromestoPDwhichintheinitialstagescanappearasPD;however,astheyearspass,certainsignsandsymptomsemergethatalertthecliniciantoanalternatediagnosis.Intheearlystages,itisdifficulttodistinguishPDfromtheseothersyndromes.However,thepresenceofearlydementia,fallingandhallucinations,aswellaslackofasignificantbenefittolevodopa,shouldwarntheclinicianthatanotherdiagnosis(LewyBodydementia,progressivesupranuclearpalsy,multiplesystemsatrophy)maybeentertained.Patientswiththeseotherconditionsoftenbenefitfromlevodopa,butnotasmuchasthosewithPD;atrialoflevodoparemainsworthwhileinthesepatients.
January2017-3
COMPARISONOFTREMORINETANDPD
EssentialTremor Parkinson’sDisease• Tremorpresentwithholdingobjectsor
performingtasks• Head/voicetremor• Bilateralonsetoftremor,usuallyhands• ETOHresponsive(1-2drinkswine/beer)• Nocogwheelrigidity• Writinglargeandshaky• Tremorbetterwithwalking• Positivefamilyhistory
• Tremorpresentatrest• Chintremor• Unilateralonsetoftremor/bradykinesia• ETOHunresponsive• Cogwheelrigidity• Smallhandwriting(micrographia)• Tremoremergeswithwalkingwithreduced
armswig;stooped,shufflinggait• Often,noclearfamilyhistory
January2017-4
2.Checklisttoguideyourin-clinicreviewofthispatientwithPDsymptoms
o SignsofPD
o NosignsofEssentialTremor
o Ruleoutdruginducedparkinsonism:metoclopramidefornausea;antipsychotics:haloperidol,pimozide,risperidone,olanzapine,aripiprazole
o NoredflagssuggestiveofanotherparkinsonianconditionotherthanParkinson’sDisease(rapidprogressionofdisability;earlydementia,falls,hallucinations,nobenefitfromlevodopa)
o Ifthereissignificantfunctionalimpairment,startlevodopa(Sinemet)(seeSection4)3.Linkstoadditionalresources
Forphysicians:
www.parkinson.org
REFERRALFORMFORCOMMUNITYACCESSIBLEREHABPROGRAM:http://www.albertahealthservices.ca/frm-104014.pdf
UniversityofCalgaryDepartmentofClinicalNeurosciencesMovementDisordersClinicwebsite:www.dcns.ca/programs/movementdisorders
http://www.parkinsonalberta.ca
http://www.uptodate.com
http://www.parkinsonclinicalguidelines.ca/sites/default/files/PhysicianGuide_Non-motor_EN.pdf
Forpatients:
UpToDate®-BeyondtheBasicsPatientInformation(freelyaccessible)
Parkinson’sAlberta:http://www.parkinsonalberta.ca/
Parkinson’sDiseaseFoundation:http://www.pdf.org/
www.michaeljfox.org4.SuspectedPDPathway
ThisAHSCalgaryZonepathwayhasbeendevelopedwithconsiderationoftheseguidelines.Thefollowingisbest-practiceclinicalpathwaysformanagementofPDintheprimarycaremedicalhome:
CALGARY AND AREA
Specialist LINK
SUSPECTED PARKINSON’S DISEASE
Drug-induced Parkinsonism:
• Psychiatric drugs (see text)• Anti-emetic drugs (example: Metoclopramide)
CHANGE IF POSSIBLETo reverse drug induced
parkinsonism.NO
RULE OUT
YES
YES
YES
Spec
ialis
t LIN
KLo
cal:
403.
910.
2551
| To
ll fre
e: 1
.844
.962
.546
5 (L
INK
)w
ww
.spe
cial
istli
nk.c
a
Red Flags • Rapid progression• Early dementia• Early falls and hallucinations• No benefit from levodopa• Dystonia• Aphasia• Trunk/limb ataxia
• T - Resting tremor• R - Cogwheel rigidity• A - Akinesia/bradykinesia• P - Postural instability
If functional disability, start Sinemet regular 100/25; consider further increase after evaluation.
January2017-6
IfapatientwithsuspectedParkinson’sDiseaseneedsandwishesmedicaltreatment(andtherearenoredflagsorevidenceofdruginducedparkinsonism),thenlevodopashouldbeinitiated.TheformulationofchoiceisSinemetregular100/25(yellowtablet).Initiatetreatmentint.i.d.dosingwithmealsstartingwith½tablett.i.d.andincreasingoverto1tablett.i.d..Atthispoint,evaluatethepatientagain-ifthepatientisbetter,itmaybebesttoleavethemedicationatthisdose.Otherpatientswillbenefitfromafurtherincreaseto2tabletst.i.d.,whichremainsamodestdose.StartingSinemet100/25
Week Breakfast Lunch Supper1 0.5 0.5 0.52 1 1 1EVALUATE3 1.5 1.5 1.54 2 2 2
Potentialsideeffectsoflevodopaareprimarilylimitedtonausea(usualmildandtransient),andmildposturalhypotension.Persistentnauseamaybetreatedbytakingthelevodopawithmealsorasmallsnackorstartingdomperidone10mg1/2hourpriortoeachdoseoflevodopaandnotexceeding10mgt.i.d..DomperidonemayprolongtheQTinterval,arisktoconsider,butcanprovidesignificantbenefittorefractorynausea. Commonerrorsinstartinglevodopaincludeschedulingthemedicationdosestoofarapart(i.e.,6a.m.and6p.m.)orstayingatalowdoseofmedication(1tablett.i.d.)despiteprogressionofsymptomsandsigns.PDisaprogressiveneurodegenerativeconditionandmedicationswillneedtobeincreasedovertime,dependingonindividualpatientneeds.